ANI Pharmaceuticals, Inc.
ANIP
$82.72
-$0.05-0.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 537.80% | 522.94% | 672.15% | -137.80% | -159.21% |
| Total Depreciation and Amortization | 17.79% | 34.97% | 51.52% | 41.38% | 27.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.69% | -13.08% | 30.27% | 231.32% | 525.94% |
| Change in Net Operating Assets | -2,286.99% | 36.32% | -30.14% | 120.62% | -97.75% |
| Cash from Operations | 158.37% | 189.34% | 83.77% | 23.58% | -30.28% |
| Capital Expenditure | -23.40% | 14.79% | 7.05% | -4.95% | -27.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | 97.91% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.76% | -2,757.18% | -551.96% | -294.88% | -87.66% |
| Cash from Investing | 94.05% | 91.52% | 89.07% | -8,892.53% | -5,899.97% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 95.90% | 96.57% | 97.24% | -9,853.10% | -9,810.40% |
| Issuance of Common Stock | 106.38% | 109.68% | 125.93% | -40.18% | -93.01% |
| Repurchase of Common Stock | -78.53% | -11.41% | -9.60% | -6.35% | -21.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 53.78% | 28.80% | 3.82% | 0.00% | 0.00% |
| Other Financing Activities | 99.96% | 99.96% | 95.32% | -146.71% | -146.71% |
| Cash from Financing | -107.88% | -103.75% | -103.96% | 1,035.45% | 425.76% |
| Foreign Exchange rate Adjustments | 128.68% | 50.43% | 1,066.67% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 304.89% | 284.62% | 344.75% | -128.41% | -148.97% |